We are live on ! Find out more
ID

Integral Derivatives Portfolio holdings

AUM $4.07B
1-Year Est. Return 19.81%
This Fund
S&P 500
This Quarter Est. Return
+1.05%
1 Year Est. Return
+19.81%
3 Year Est. Return
+45.77%
5 Year Est. Return
10 Year Est. Return
AUM
$5.4B
AUM Growth
+$612M
Cap. Flow
+$41M
Cap. Flow %
0.76%
Top 10 Hldgs %
51.53%
Holding
1,375
New
399
Increased
402
Reduced
270
Closed
267

Top Buys

Rank Stock Value
1
BABA icon
Alibaba
BABA
+$20.3M
2
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$10.8M
3
BIDU icon
Baidu
BIDU
+$6.27M
4
CMCSA icon
Comcast
CMCSA
+$5.98M
5
MSFT icon
Microsoft
MSFT
+$5.98M

Top Sells

Rank Stock Value
1
LMT icon
Lockheed Martin
LMT
+$16.2M
2
YHOO
Yahoo Inc
YHOO
+$8.75M
3
BAC icon
Bank of America
BAC
+$8.19M
4
CVX icon
Chevron
CVX
+$6.68M
5
LNKD
LinkedIn Corporation
LNKD
+$6.14M

Sector Composition

Rank Sector Weight
1 Miscellaneous 93.2%
2 Communication Services 1.81%
3 Energy 1.34%
4 Technology 0.97%
5 Consumer Discretionary 0.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NVAX icon
1101
CALL
Novavax
NVAX
$1.49B
$25K ﹤0.01%
985
+295
+43% +$8.6K
VNR
1102
CALL
DELISTED
Vanguard Natural Resources, LLC
VNR
$23K ﹤0.01%
+33,700
New +$24.4K
MNKD icon
1103
CALL
MannKind Corp
MNKD
$1.31B
$22K ﹤0.01%
+6,900
New +$20K
CRMD icon
1104
PUT
CorMedix
CRMD
$648M
$21K ﹤0.01%
+2,740
New +$27.7K
CRMD icon
1105
CorMedix
CRMD
$648M
$17K ﹤0.01%
+2,280
New +$23.1K
ANTH
1106
CALL
DELISTED
Anthera Pharmaceuticals, Inc.
ANTH
$11K ﹤0.01%
+2,125
New +$36.8K
MNKD icon
1107
PUT
MannKind Corp
MNKD
$1.31B
$7K ﹤0.01%
+2,120
New +$6.13K
SVRA icon
1108
CALL
Savara
SVRA
$1.13B
$1K ﹤0.01%
154
AAOI icon
1109
Applied Optoelectronics
AAOI
$9.62B
-22,015
Closed -$510K
ABT icon
1110
PUT
Abbott
ABT
$193B
-17,600
Closed -$744K
ADBE icon
1111
Adobe
ADBE
$115B
-6,045
Closed -$640K
ADI icon
1112
Analog Devices
ADI
$181B
-3,842
Closed -$261K
ADI icon
1113
PUT
Analog Devices
ADI
$181B
-17,900
Closed -$1.15M
AG icon
1114
PUT
First Majestic Silver
AG
$10.7B
-16,900
Closed -$174K
AKAM icon
1115
PUT
Akamai
AKAM
$16B
-11,700
Closed -$620K
AKBA icon
1116
CALL
Akebia Therapeutics
AKBA
$260M
-19,900
Closed -$180K
AKBA icon
1117
PUT
Akebia Therapeutics
AKBA
$260M
-15,200
Closed -$138K
ALK icon
1118
PUT
Alaska Air
ALK
$4.71B
-3,700
Closed -$244K
ALNY icon
1119
CALL
Alnylam Pharmaceuticals
ALNY
$31.7B
-3,200
Closed -$217K
AMKR icon
1120
Amkor Technology
AMKR
$12.9B
-11,600
Closed -$113K
AMT icon
1121
CALL
American Tower
AMT
$81.2B
-8,000
Closed -$907K
ANGI icon
1122
Angi Inc
ANGI
$189M
-1,046
Closed -$104K
ASH icon
1123
CALL
Ashland
ASH
$3.39B
-27,594
Closed -$1.56M
ASHR icon
1124
CALL
Xtrackers Harvest CSI 300 China A-Shares ETF
ASHR
$1.57B
-58,800
Closed -$1.45M
ASML icon
1125
CALL
ASML
ASML
$666B
-6,100
Closed -$668K

Similar funds

Integral Derivatives's Q4 2016 Portfolio in Review

As of Q4 2016, Integral Derivatives held 1,375 positions worth $5.4B, up 13% from $4.78B the previous quarter. Its ten largest holdings account for 52% of the portfolio.

Integral Derivatives's Q4 2016 filing shows 399 new, 402 increased, 270 reduced and 267 closed positions. Its largest new stake was Alibaba: 210,683 shares worth $18.5M. The largest sale was Lockheed Martin, an estimated $16.2M.

By sector, the portfolio is most concentrated in Miscellaneous at 93% of assets, up from 93% a quarter earlier, followed by Communication Services and Energy.

  • Integral Derivatives's largest Q4 2016 buy was Alibaba: 210,683 shares worth $18.5M.
  • Integral Derivatives added most to Alphabet (Google) Class A in Q4 2016, an estimated $10.8M increase.
  • Integral Derivatives's biggest Q4 2016 reduction was Lockheed Martin, cutting an estimated $16.2M.
  • Integral Derivatives fully exited LinkedIn Corporation in Q4 2016, selling an estimated $6.14M.
  • Integral Derivatives's ten largest holdings make up 52% of its $5.4B portfolio in Q4 2016.
  • Integral Derivatives opened 399 new positions and closed 267 in Q4 2016.
  • Integral Derivatives's portfolio value rose 13% quarter-over-quarter to $5.4B.

Based on Integral Derivatives's 13F filing for Q4 2016, filed 14 Feb 2017.